Header cover image

Norwegian (OSEAX) Healthcare Sector Analysis

UpdatedJan 30, 2025
DataAggregated Company Financials
Companies25
  • 7D2.1%
  • 3M0.7%
  • 1Y-35.0%
  • YTD0.1%

In the last week, the Healthcare industry is up 2.6%, with Medistim up 5.1%. In the same time, Oncoinvent was down 17%. In the past year, the industry is down 34%. Looking forward, earnings are forecast to grow by 49% annually.

Sector Valuation and Performance

Has the Norwegian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 30 Jan 2025NOK 16.8bNOK 3.8b-NOK 1,104,834,227.1924.9x-15.2x4.5x
Sat, 28 Dec 2024NOK 16.1bNOK 3.8b-NOK 1,107,665,857.5625.6x-14.5x4.3x
Mon, 25 Nov 2024NOK 16.6bNOK 4.0b-NOK 980,024,949.4323.3x-17x4.1x
Wed, 23 Oct 2024NOK 17.6bNOK 4.0b-NOK 975,910,616.7320.1x-18x4.4x
Fri, 20 Sep 2024NOK 18.4bNOK 4.0b-NOK 952,470,634.8919.4x-19.4x4.6x
Sun, 18 Aug 2024NOK 21.2bNOK 4.0b-NOK 922,580,043.3620.3x-23x5.2x
Tue, 16 Jul 2024NOK 21.8bNOK 4.0b-NOK 973,712,869.8216.9x-22.4x5.4x
Thu, 13 Jun 2024NOK 23.0bNOK 4.2b-NOK 1,128,672,257.2117.6x-20.4x5.4x
Sat, 11 May 2024NOK 21.5bNOK 4.2b-NOK 1,131,496,368.7818.6x-19x5.1x
Mon, 08 Apr 2024NOK 22.0bNOK 4.2b-NOK 1,114,344,892.3328.8x-19.7x5.3x
Wed, 06 Mar 2024NOK 26.0bNOK 4.2b-NOK 1,083,735,913.3528.4x-24x6.2x
Fri, 02 Feb 2024NOK 29.3bNOK 4.1b-NOK 1,585,917,333.0023.6x-18.5x7.2x
Sun, 31 Dec 2023NOK 30.4bNOK 4.1b-NOK 1,574,472,572.0023.2x-19.3x7.5x
Tue, 28 Nov 2023NOK 27.8bNOK 4.1b-NOK 1,586,213,378.0021.5x-17.6x6.8x
Thu, 26 Oct 2023NOK 25.0bNOK 3.4b-NOK 1,903,058,503.0031.5x-13.1x7.3x
Sat, 23 Sep 2023NOK 28.7bNOK 3.6b-NOK 1,809,687,577.0033.4x-15.9x8.1x
Mon, 21 Aug 2023NOK 28.3bNOK 3.5b-NOK 1,849,937,079.0032.7x-15.3x8.2x
Wed, 19 Jul 2023NOK 28.9bNOK 3.4b-NOK 1,814,620,112.0030.2x-15.9x8.6x
Fri, 16 Jun 2023NOK 30.3bNOK 3.4b-NOK 1,837,616,377.0042.1x-16.5x9x
Sun, 14 May 2023NOK 30.2bNOK 3.4b-NOK 1,789,119,443.0044.3x-16.9x8.9x
Tue, 11 Apr 2023NOK 29.8bNOK 3.1b-NOK 1,865,655,128.0031.7x-16x9.6x
Thu, 09 Mar 2023NOK 30.0bNOK 3.1b-NOK 2,020,747,994.0030.4x-14.8x9.6x
Sat, 04 Feb 2023NOK 34.4bNOK 3.6b-NOK 1,859,551,961.0034.9x-18.5x9.6x
Mon, 02 Jan 2023NOK 34.1bNOK 3.6b-NOK 1,831,061,110.0035.9x-18.6x9.6x
Wed, 30 Nov 2022NOK 32.8bNOK 3.6b-NOK 1,827,716,959.0038.9x-18x9.2x
Fri, 28 Oct 2022NOK 31.6bNOK 3.4b-NOK 1,740,954,911.0039.1x-18.2x9.2x
Sun, 25 Sep 2022NOK 29.9bNOK 3.4b-NOK 1,774,795,953.0053.9x-16.8x8.7x
Tue, 23 Aug 2022NOK 37.5bNOK 3.3b-NOK 1,733,766,932.0062.6x-21.7x11.3x
Thu, 21 Jul 2022NOK 37.3bNOK 3.3b-NOK 1,743,337,857.0082.4x-21.4x11.3x
Sat, 18 Jun 2022NOK 36.7bNOK 3.7b-NOK 1,359,401,050.0058.1x-27x10.1x
Mon, 16 May 2022NOK 35.9bNOK 3.5b-NOK 1,240,056,127.0047.3x-28.9x10.1x
Wed, 13 Apr 2022NOK 42.4bNOK 3.5b-NOK 1,201,678,665.0043.9x-35.3x12.3x
Fri, 11 Mar 2022NOK 41.3bNOK 5.1bNOK 204.2m40x202x8x
Sun, 06 Feb 2022NOK 50.9bNOK 4.9bNOK 281.5m45.6x180.9x10.3x
Price to Earnings Ratio

180.9x


Total Market Cap: NOK 50.9bTotal Earnings: NOK 281.5mTotal Revenue: NOK 4.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Norwegian Healthcare Sector Price to Earnings3Y Average -7.5x202320242025
Current Industry PE
  • Investors are pessimistic on the Norwegian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 7.8x is higher than the industry's current PS ratio of 4.4x.
Past Earnings Growth
  • Total earnings for the Healthcare industry have declined over the last three years, with the industry now making a loss overall.
  • Revenues have also declined 8.7% per year, which is driving profits down.

Industry Trends

Which industries have driven the changes within the Norwegian Healthcare sector?

NO Market1.24%
Healthcare2.07%
Medical Equipment6.33%
Healthcare Services5.99%
Pharma3.53%
Biotech1.54%
Life Sciences0%0
Healthtech-2.03%
Industry PE
  • Investors are most optimistic about the Pharma industry which is trading above its 3-year average PE ratio of 31.9x.
    • Analysts are expecting annual earnings growth of 80.1%, which is higher than its past year's earnings growth of 0.7% per year.
Forecasted Growth
  • Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 80% over the next 5 years.
  • This is better than its past earnings growth rate of 0.7% per year.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 15% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
MEDI MedistimNOK 158.507.8%
+NOK 210.6m
-26.6%PE28.6x
HBC Hofseth BioCareNOK 3.1510.5%
+NOK 123.3m
32.4%PS5.2x
PHO PhotocureNOK 55.805.7%
+NOK 81.3m
-14.7%PE106.8x
NORDH NordhealthNOK 41.501.7%
+NOK 55.3m
54.9%PS6.4x
AZT ArcticZymes TechnologiesNOK 14.543.9%
+NOK 27.6m
-57.0%PE160.5x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

TRMED

NOK 2.61

Thor Medical

7D

-7.3%

1Y

127.0%

INIFY

NOK 4.70

INIFY Laboratories

7D

11.9%

1Y

-60.8%

GENT

NOK 45.00

Gentian Diagnostics

7D

0.9%

1Y

9.8%

ONCIN

NOK 2.60

Oncoinvent

7D

-4.4%

1Y

n/a

NORDH

NOK 41.50

Nordhealth

7D

1.7%

1Y

54.9%

LIFE

NOK 12.00

Lifecare

7D

-3.6%

1Y

-76.8%

BGBIO

NOK 7.98

BerGenBio

7D

-4.4%

1Y

-70.2%

NYKD

NOK 2.63

Nykode Therapeutics

7D

-4.6%

1Y

-85.3%

MEDI

NOK 158.50

Medistim

7D

7.8%

1Y

-26.6%

NAVA

NOK 24.00

Navamedic

7D

-2.0%

1Y

-37.7%

CONTX

NOK 5.16

ContextVision

7D

1.2%

1Y

-42.5%

HBC

NOK 3.15

Hofseth BioCare

7D

10.5%

1Y

32.4%

VISTN

NOK 23.50

Vistin Pharma

7D

-2.1%

1Y

-0.8%